Mirjam Blattner
74 works · 2,705 citations · h-index 17
Top works
- Sarcoma classification by DNA methylation profiling
- Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover
- Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
- Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer
- Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men
- SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts
- SPOP mutation leads to genomic instability in prostate cancer
- SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling
- mtDNA Segregation in Heteroplasmic Tissues Is Common In Vivo and Modulated by Haplotype Differences and Developmental Stage
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis
- Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
- Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity
- Inherited determinants of early recurrent somatic mutations in prostate cancer
- Combined ultra-low input mRNA and whole-genome sequencing of human embryonic stem cells
- CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis
- Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity
- SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG
- Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients
- Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4